Last reviewed · How we verify
Intestinal microbiota capsules — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intestinal microbiota capsules (Intestinal microbiota capsules) — First Affiliated Hospital of Ningbo University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intestinal microbiota capsules TARGET | Intestinal microbiota capsules | First Affiliated Hospital of Ningbo University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intestinal microbiota capsules CI watch — RSS
- Intestinal microbiota capsules CI watch — Atom
- Intestinal microbiota capsules CI watch — JSON
- Intestinal microbiota capsules alone — RSS
Cite this brief
Drug Landscape (2026). Intestinal microbiota capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/intestinal-microbiota-capsules. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing